CD19-targeted CAR T Cells for Relapsed and Refractory (R/R) Non-Hodgkins Lymphoma

Clinical trial NCT04089215 · UNKNOWN

Trial details

NCT number: NCT04089215
Sponsor: Shanghai Ming Ju Biotechnology Co., Ltd.
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Lymphoma, Non-Hodgkin Diffuse Large B Cell Lymphoma Follicular Lymphoma

Start date: 2019-06-11
Primary completion: 2021-09-10
Enrollment: 82

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.